Atlas Trials

Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)

Clinical trial NCT04583358 · UNKNOWN

Trial details

NCT number
NCT04583358
Sponsor
Applied Molecular Transport
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2020-08-26
Primary completion
2022-11-30
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.